About SillaJen
SillaJen is a company based in Busan (South Korea) founded in 2006.. SillaJen has raised $12 million across 1 funding round from investors including Medivate Partners. The company has 45 employees as of December 31, 2024. SillaJen has completed 1 acquisition, including Jennerex Biotherapeutics. SillaJen offers products and services including Marketing Services, Education Programs, and Consulting Services. SillaJen operates in a competitive market with competitors including Replimune, Candel Therapeutics, Adlai Nortye, Transgene and Nouscom, among others.
- Headquarter Busan, South Korea
- Employees 45 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sillajen, Inc.
-
Annual Revenue
$2.66 M (USD)-0.33as on Dec 31, 2024
-
Net Profit
$-17.99 M (USD)-30.22as on Dec 31, 2024
-
EBITDA
$-17.47 M (USD)-26.75as on Dec 31, 2024
-
Total Equity Funding
$12 M (USD)
in 1 rounds
-
Latest Funding Round
$12 M (USD), Private Equity Round
Mar 21, 2016
- Investors
-
Employee Count
45
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SillaJen
SillaJen is a publicly listed company on the KRX with ticker symbol 215600 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SillaJen
SillaJen offers a comprehensive portfolio of products and services, including Marketing Services, Education Programs, and Consulting Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides strategies for salon promotion and online visibility
Offers courses on beauty business management and marketing
Delivers advice on salon operations and client analysis
Unlock access to complete
Product Management Team
2 people
Leadership Team
1 people
Drug Team
1 people
COO Team
1 people
Unlock access to complete
Funding Insights of SillaJen
SillaJen has successfully raised a total of $12M through 1 strategic funding round. The most recent funding activity was a Private Equity Round round of $12 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $12.0M
-
First Round
First Round
(21 Mar 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2016 | Amount | Private Equity Round - SillaJen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SillaJen
SillaJen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Medivate Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SillaJen
SillaJen has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Jennerex Biotherapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Oncolytic viruses for cancer treatment are developed by the company.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SillaJen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sillajen Comparisons
Competitors of SillaJen
SillaJen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Replimune, Candel Therapeutics, Adlai Nortye, Transgene and Nouscom, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of oncolytic immunotherapies
|
|
| domain | founded_year | HQ Location |
Viral immunotherapies are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Immune oncolytic therapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic vaccines for cancer and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Viral-vector-based vaccines for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sillajen
Frequently Asked Questions about SillaJen
When was SillaJen founded?
SillaJen was founded in 2006 and raised its 1st funding round 10 years after it was founded.
Where is SillaJen located?
SillaJen is headquartered in Busan, South Korea.
Is SillaJen a funded company?
SillaJen is a funded company, having raised a total of $12M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $12M, raised on Mar 21, 2016.
How many employees does SillaJen have?
As of Dec 31, 2024, the latest employee count at SillaJen is 45.
What is the annual revenue of SillaJen?
Annual revenue of SillaJen is $2.66M as on Dec 31, 2024.
What does SillaJen do?
SillaJen was founded in 2006 and is based in Busan, South Korea. Operations focus on the biotechnology sector, where oncolytic immunotherapeutics are developed to treat various cancers. The lead product candidate, Pexa-Vec, an engineered oncolytic virus, targets advanced primary liver cancer and is in mid-stage development for kidney cancer and other solid tumors. Research emphasizes viral therapies to enhance immune responses against tumors.
Who are the top competitors of SillaJen?
SillaJen's top competitors include Replimune, Vyriad and Candel Therapeutics.
What products or services does SillaJen offer?
SillaJen offers Marketing Services, Education Programs, and Consulting Services.
Is SillaJen publicly traded?
Yes, SillaJen is publicly traded on KRX under the ticker symbol 215600.
How many acquisitions has SillaJen made?
SillaJen has made 1 acquisition, including Jennerex Biotherapeutics.
Who are SillaJen's investors?
SillaJen has 1 investor. Key investors include Medivate Partners.
What is SillaJen's ticker symbol?
The ticker symbol of SillaJen is 215600 on KRX.